TEZSPIRE – Newest FDA-Approved Biologic for Severe Asthma
Neal Jain discusses asthma, severe asthma, and AstraZeneca and Amgen's Tezspire™ (tezepelumab-ekko), the newest FDA-approved biologic for severe asthma.
270 articles
Neal Jain discusses asthma, severe asthma, and AstraZeneca and Amgen's Tezspire™ (tezepelumab-ekko), the newest FDA-approved biologic for severe asthma.
Physiotherapy is a form of healthcare that aims to help people recover from physical injuries or conditions. Learn more on Health Professional Radio.
Matthew Weir, Attending Physician and Director of the Division of Nephrology in the Department of Medicine at the University of Maryland Hospital discus...
Returning guest, James Sapirstein, President and CEO of First Wave BioPharma (formerly AzurRX), a developer of targeted therapies for gastrointestinal (...
Bill Hinshaw, President and CEO of Axcella Therapeutics, discusses the initiation of a pioneering Phase 2a clinical trial in long COVID, investigating A...
In this segment, Neal speaks with healthcare veteran Nancy Lurker, President and CEO of EyePoint Pharmaceuticals, who discussed how Lurker transformed E...
Soumya Chakravarty, MD, Ph.D., Senior Director & Strategic Lead, Rheumatology Therapeutic Area, U.S. Learn more on Health Professional Radio.
Obesity is a well-known health issue experienced by so many people. Learn more on Health Professional Radio.
Janssen Immunology has a track record of defining and redefining the treatment of immune-mediated disease. Learn more on Health Professional Radio.
For patients suffering from chronic pain or movement disorders who don't live close to a care provider or have difficulty accessing care for a variety o...